The Commercial Space Company
....
Astronaut Story Musgrave operating the Optical DMDA on board Shuttle flight STS-80.
Space Shuttle Columbia carrying ITAs CMIX-5 payload, climbs skyward on the STS-80 mission.
ITA:
ITA protects your proprietary rights:
STS067 Astronaut William G. Gregory, pilot, works with a pharmaceutical experiment on the middeck of the Earth-orbiting Space Shuttle Endeavour during the STS-67 mission. Commercial Materials Dispersion Apparatus Instrumentation Technology Associates Experiments (CMIX-03) includes not only pharmaceutical, but also biotechnology, cell biology, fluids, and crystal growth investigations.
STS-37 Commander Steven R. Nagel (left) and Mission Specialist (MS) Jerome Apt shake a cell syringe during a test with the Bioserve Instrumentation Technology Associates Materials Dispersion Apparatus (BIMDA) bioprocessing test bed. The crewmembers are on the middeck of Atlantis, Orbiter Vehicle (OV) 104. The BIMDA payload was developed and built by ITA, and flown jointly under the auspices of BioServe Space Technologies, a NASA Center for Commercial Development of Space (CCDS) located at the University of Colorado. Also collaborating on the BIMDA activity are researchers from NASA Johnson Space Center (JSC) in Texas and Ames Research Center (ARC) in California. Apt stands near the sleep restraints attached to the starboard wall.
For further information about ITA or to receive a brochure, please send us